1 / 66

The Management of Seizures and SE in the Emergency Department

The Management of Seizures and SE in the Emergency Department. Edward Sloan, MD, MPH, FACEP. Associate Professor & Research Development Director Department of Emergency Medicine, University of Illinois at Chicago Chicago, IL (edsloan@uic.edu). Global Objectives.

myron
Download Presentation

The Management of Seizures and SE in the Emergency Department

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. The Management of Seizures and SE in the Emergency Department

  2. Edward Sloan, MD, MPH, FACEP Associate Professor & Research Development Director Department of Emergency Medicine, University of Illinois at Chicago Chicago, IL (edsloan@uic.edu)

  3. Global Objectives • Learn more about seizures • Increase awareness of Rx options • Enhance our ED management • Improve patient care & outcomes • Maximize staff & patient satisfaction • Be prepared for the EM board exam

  4. Session Objectives • Provide seizure and SE overview • Summarize what Rx options exist • Discuss specific sub-groups • Outline ED Rx strategies

  5. Sz Epidemiology: • Epilepsy seen in 1/150 people • For each epilepsy pt, 1 ED visit every 4 years • 1-2% of all ED visits • Significant costs

  6. Seizure Mechanism: • Sz = abnormal neuronal discharge with recruitment of otherwise normal neurons • Loss of GABA inhibition

  7. Pathophysiology: • Glutamate toxic mediator • Necrosis occurs even if systemic problems are treated (HTN, fever, rhabdomyolysis, resp acidosis, hypoxia)

  8. Pathophysiology: • Early compensation for increased CNS metabolic needs • Decompensation at 40-60 minutes, associated with tissue necrosis

  9. Seizure Classification: • Generalized: both cerebral hemispheres • Partial: one cerebral hemisphere

  10. Generalized Seizures : • Convulsive: tonic-clonic • Non-convulsive: absence

  11. Generalized Seizures : • Primary generalized: starts as tonic-clonic seizure • Secondarily generalized: tonic-clonic seizure occurs as a consequence of a non-convulsive seizure

  12. Partial Seizures : • Simple partial: no impaired consciousness • Complex partial: impaired consciousness

  13. Specific Seizure Types : • Absence: Petit mal • Partial: Jacksonian, focal motor • Complex partial: temporal lobe, psychomotor

  14. Status Epilepticus: • Sz > 5- 10 minutes = SE • Two sz without a lucid interval = SE (Assumes ongoing sz during coma)

  15. SE Epidemiology: • Risk of SE greatest at extremes of age: pediatric and geriatric populations • SE: occurs in setting of acute insult, chronic epilepsy, or new onset seizure • 150,000 cases per year

  16. SE Classification: • GCSE: Generalized convulsive SE, with tonic-clonic motor activity • Non-GCSE

  17. Two Non-GCSE Types: • Non-convulsive SE • Absence SE • Complex-partial SE • Subtle SE • Late generalized convulsive SE • Coma, persistent ictal discharge • Very grave prognosis

  18. AMS in Seizures: • Mental status should improve by 20-40 minutes • If pt comatose, then subtle SE is possible: EEG • Up to 20% of pts with coma still are in SE

  19. Ongoing SE Effects: • Over 40-60 min, loss of metabolic compensation • With ongoing SE, systemic BP & CBF drop

  20. SE Mortality: • SE mortality > 30% when sz longer than 60 minutes • Underlying sz etiology contributes to mortality

  21. Subtle SE: • Mortality exceeds 50% • Often after hypoxic insult • Coma • Limited motor activity • Stop the sz, EEG confirm

  22. General ED Management: • ABCs • Glucose, narcan, thiamine • Rapid sequential use of AEDs • Directed evaluation

  23. Lab Evaluation: • Key lab abnormality: hypoglycemia, in up to 2% • Directed labs, including anti-epileptic drug levels

  24. Lumbar Puncture: • Fever and CSF pleocytosis can occur in SE without meningitis • Use clinical criteria to determine LP need • AMS, immunocompromise, meningismus

  25. Neuroimaging with CT: • CT useful with focal sz, change in sz type or frequency, co-morbidity • Req’d in new-onset sz • Non-contrast unless mass lesion suspected

  26. Neuroimaging with MRI: • Useful with refractory sz • Complements plain CT • Can be done as outpt

  27. EEG Monitoring: • EEG to rule out subtle SE • Prolonged coma, RSI, induced coma with propofol, pentobarbital • Obtain EEG in 120 minutes • Two-lead EEG in ED

  28. AED loading: • Repeated seizures, high-risk population, significant SE risk • No need to determine level in ED after loading • Oral loading in low risk pts

  29. Hospital Admission: • Repeated sz, high-risk pt, significant SE risk • Esp if no AED loading • New-onset seizure: admission is preferred (complete w/u, observe)

  30. New-Onset Sz: Recurrent Sz • 51% recurrence risk • 75% of recurrent sz occur within 2 years of first sz • Only a small % of pts will seize within 24 h • Partial sz, CNS abn inc risk

  31. ED Discharge: • Follow-up & EEG needed, esp if no AED prescribed • Driving documentation is critical. Know state law.

  32. Pharmacotherapy of Seizures • Benzodiazepines • Phenytoins • Barbiturates • Other agents • valproate • propofol

  33. General AED Concepts: • Most drugs are at least 80% effective in Rx seizures, SE • Have AEDs available in ED • Maximize infusion rate in SE • Use full mg/kg doses

  34. Benzodiazepines: • GABA drug • Diazepam: short acting, limited AMS and protection • Lorazepam: prolonged AMS and protection • Pediatric sz: IV lorazepam limits respiratory compromise

  35. Rectal Diazepam: • Diazepam rectal gel pre-packaged for rapid use • Dose 0.5 mg/kg, less respiratory depression seen than with IV use

  36. Phenytoin: • Phenytoin: Na+ channel Rx • Load at 18 mg/kg, 1.5 doses • Infuse at 50 mg/min max • Use pump to prevent comp • Level 10-20 µg/mL

  37. Fosphenytoin: • Fos: pro-drug, dose same • Infuse at 150 mg/min in SE • Can be given IM up to 20cc • Level 10-20 µg/mL • Delayed level: 2h IV, 4 h IM

  38. IV Phenobarbital: • GABA-like, effective sz Rx • Limited availability • Infuse up to 50 mg/min • 20-30 mg/kg, 10 mg/kg doses • Level > 40 µg/mL

  39. IV Valproate: • Likely GABA mechanism • Useful in peds, possibly SE • Rate up to 300 mg/min • 25-30 mg/kg, 3-6 mg/kg/min • Level > 100 µg/mL

  40. Refractory SE: • SE refractory to benzos, phts, phenobarb, valproate • Propofol, pentobarb: useful third line agents • Midazolam infusion also useful • Respiratory depression, BP • Must control airway, get EEG

  41. IV Propofol: • Likely GABA mechanism • Provides burst suppression • 2 mg/kg loading dose • Hypotension, resp depression, acidosis • Easily reversed

  42. IV Pentobarbital: • Likely GABA mechanism • Provides burst suppression • 5 mg/kg loading dose • 25 mg/kg infusion rate • ICU monitoring required

  43. ED Treatment Protocol: • Have AEDs easily available • Rapid sequential AED use • Maximize infusion rate • Maximize mg/kg dosing • Benzos, phenytoins, phenobarbital, valproate

  44. No IV Access: • PR diazepam • IM midazolam • IM fosphenytoin • Buccal, intranasal midazolam • No IM phenytoin/phenobarbital

  45. Special Populations • Drug and alcohol-related seizures • Acute CVA • Post-traumatic • Pregnancy • Pediatrics • Elderly • Psychogenic seizures

  46. Drug-related Sz: • Stimulants, anti-depressants, theophylline and cocaine commonly can cause sz • Most sz treated with benzos • Phenytoin less useful

  47. Drug-related Sz Rx: • INH: Blocks GABA production • Vit B6, pyridoxine • 5 gr IVP x 6, match ingestion gr • Theophylline: eliminate with hemodialysis, hemoperfusion • Tricyclics, cocaine: benzos,?? utility of other drugs

  48. EtOH-related Seizures: • Occur 12 hrs p last drink • Lorazepam optimal Rx for sz • Lorazepam in DTs and sz prevention • Phenytoin ?? sz flurries, SE

  49. Seizures in Acute CVA: • Seizures can occur in stroke • Consider prophylaxis with elderly, large hemorrhage, anterior CVA location

  50. Post-traumatic Seizures: • High-risk populations exist • Early prophylaxis stops early sz, not late sz onset • Phenytoins, valproate

More Related